Sign In
Get Clay Free →

Suggestions

    Martin Silverstein

    President and Chief Executive Officer at Mana Therapeutics, Inc

    Martin Silverstein, M.D., is an advisor to CEOs, C-suite, and boards of industry leaders in life sciences and healthcare, with a track record in enhancing business performance.1 He is recognized for his thought leadership and pragmatic approach.1

    Experience and Roles::

    • Ardan Equity: Currently an Executive Partner at Ardan Equity since June 2022, a healthcare software private equity firm.1
    • Angiocrine Bioscience, Inc.: He has been a Board Member since January 2022.1
    • Mana Therapeutics: Served as President and Chief Executive Officer from November 2018 to May 2022.1 Prior to May 2022, he had been the President and Chief Executive Officer for MANA Therapeutics since its founding in November 2018.4 MANA Therapeutics is a start-up clinical stage biotech company that focuses on cell-based therapies that eliminate cancer cells.1 In October 2024, it was noted that MANA Therapeutics had recruited an experienced leadership team from industry, including Martin B. Silverstein as president and CEO.3
    • Gilead Sciences: He was Executive Vice President, Strategy from June 2016 to September 2018.1 Dr. Silverstein oversaw Gilead’s corporate development, commercial planning, and alliance management functions.2
    • Anthem, Inc.: Served as Executive Vice President and Chief Strategy Officer from April 2014 to December 2015.1
    • The Boston Consulting Group: He was a Senior Partner and Managing Director from 1986 to 2014.1 He held positions such as Global Leader of Health Care Practice (2006 - 2011), and Leader of America's Health Care Practice (1999-2006).1
    • Health Data Institute: He was a Senior Scientist from 1983 to 1985.1

    Education::

    • Yale University School of Medicine: Earned an M.D. in Internal Medicine.1
    • University of Pennsylvania: Received a BA in Economics & Natural Sciences.1
    • Harvard Business School: Obtained an MBA.1

    Highlights

    Children's National spin-out cell therapy company receives funding
    Aug 30 · marketscreener.com
    Martin J. Silverstein: Positions, Relations and Network
    May 24 · gilead.com
    Gilead Sciences Announces Appointment of Kevin Young CBE as ...

    Related Questions

    What are Martin Silverstein's key achievements at Mana Therapeutics?
    How did Martin Silverstein transition from Gilead Sciences to Anthem, Inc?
    What strategies did Martin Silverstein implement at The Boston Consulting Group?
    What is the focus of Mana Therapeutics under Martin Silverstein's leadership?
    How has Martin Silverstein's experience at Ardan Equity influenced his approach at Mana Therapeutics?
    Martin Silverstein
    Martin Silverstein, photo 1
    Martin Silverstein, photo 2
    Add to my network

    Location

    Greater Boston Area